A detailed history of Banque Cantonale Vaudoise transactions in Novo Nordisk A S stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 9,650 shares of NVO stock, worth $1.02 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
9,650
Previous 9,823 1.76%
Holding current value
$1.02 Million
Previous $1.4 Million 18.18%
% of portfolio
0.05%
Previous 0.06%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.07 - $145.42 $20,599 - $25,157
-173 Reduced 1.76%
9,650 $1.15 Million
Q2 2024

Jul 31, 2024

SELL
$122.71 - $146.91 $54,483 - $65,228
-444 Reduced 4.32%
9,823 $1.4 Million
Q1 2024

Apr 10, 2024

BUY
$102.11 - $135.92 $980,562 - $1.31 Million
9,603 Added 1446.23%
10,267 $1.32 Million
Q3 2023

Nov 08, 2023

SELL
$90.94 - $199.54 $2,819 - $6,185
-31 Reduced 4.46%
664 $60,000
Q2 2023

Aug 09, 2023

SELL
$155.98 - $172.65 $72,218 - $79,936
-463 Reduced 39.98%
695 $113,000
Q1 2023

Apr 20, 2023

SELL
$132.34 - $159.14 $84,962 - $102,167
-642 Reduced 35.67%
1,158 $184,000
Q4 2022

Feb 10, 2023

SELL
$102.55 - $135.33 $17,228 - $22,735
-168 Reduced 8.54%
1,800 $243,000
Q3 2022

Oct 17, 2022

BUY
$95.28 - $116.93 $19,627 - $24,087
206 Added 11.69%
1,968 $197,000
Q2 2022

Aug 02, 2022

BUY
$103.24 - $121.81 $5,471 - $6,455
53 Added 3.1%
1,762 $197,000
Q1 2022

May 09, 2022

SELL
$93.1 - $112.54 $62,935 - $76,077
-676 Reduced 28.34%
1,709 $189,000
Q4 2021

Feb 14, 2022

SELL
$95.88 - $117.08 $13,231 - $16,157
-138 Reduced 5.47%
2,385 $267,000
Q3 2021

Oct 29, 2021

SELL
$84.42 - $106.62 $11,143 - $14,073
-132 Reduced 4.97%
2,523 $242,000
Q2 2021

Aug 11, 2021

BUY
$67.66 - $84.76 $179,637 - $225,037
2,655 New
2,655 $222,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Banque Cantonale Vaudoise Portfolio

Follow Banque Cantonale Vaudoise and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.